The publisher's Medical Devices sector report, 'Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Topical Absorbable Hemostats pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Topical Absorbable Hemostats under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Topical Absorbable Hemostats under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
1.2 List of Figures
2 Introduction
2.1 Topical Absorbable Hemostats Overview
3 Products under Development
3.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development
3.2 Topical Absorbable Hemostats - Pipeline Products by Segment
3.3 Topical Absorbable Hemostats - Pipeline Products by Territory
3.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
3.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
3.6 Topical Absorbable Hemostats - Ongoing Clinical Trials
3.2 Topical Absorbable Hemostats - Pipeline Products by Segment
3.3 Topical Absorbable Hemostats - Pipeline Products by Territory
3.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
3.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
3.6 Topical Absorbable Hemostats - Ongoing Clinical Trials
4 Topical Absorbable Hemostats - Pipeline Products under Development by Companies
4.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
4.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development
4.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development
5 Topical Absorbable Hemostats Companies and Product Overview
5.1 3-D Matrix Ltd Company Overview
5.2 Acro Biomedical Co Ltd Company Overview
5.3 Advanced Biotech Products Pvt Ltd Company Overview
5.4 Angiotech Pharmaceuticals Inc Company Overview
5.5 Anika Therapeutics Inc Company Overview
5.6 APRUS Bio-Medical Innovations Pvt Ltd Company Overview
5.7 Arch Therapeutics Inc Company Overview
5.8 Baxter Healthcare Corp Company Overview
5.9 Beth Israel Deaconess Medical Center Company Overview
5.10 Biomedica Management Corp Company Overview
5.11 Biom'Up SAS Company Overview
5.12 Cellphire Inc Company Overview
5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview
5.14 Columbia University Company Overview
5.15 Covalent Medical, Inc. (Inactive) Company Overview
5.16 Covalon Technologies Ltd Company Overview
5.17 CR Bard Inc Company Overview
5.18 Cresilon Inc Company Overview
5.19 Endomedix Incorporated Company Overview
5.20 Entegrion Inc Company Overview
5.21 Ethicon US LLC Company Overview
5.22 ETX Pharma Inc Company Overview
5.23 Gamma Diagnostics Inc Company Overview
5.24 GATT Technologies BV Company Overview
5.25 Haemostatix Ltd Company Overview
5.26 Hemostasis LLC Company Overview
5.27 HLL Lifecare Ltd Company Overview
5.28 Ichor Sciences LLC Company Overview
5.29 Keratin Biosciences Inc Company Overview
5.30 Leader Biomedical Europe BV Company Overview
5.31 Medcura Inc Company Overview
5.32 Protege Biomedical LLC Company Overview
5.33 Resorba GmbH Company Overview
5.34 Rice University Company Overview
5.35 Sanofi Biosurgery Inc Company Overview
5.36 Sea Run Holdings Inc Company Overview
5.37 St Teresa Medical Inc Company Overview
5.38 STB Lifesaving Technologies Company Overview
5.39 Tectum Company Overview
5.40 The Medicines Co Company Overview
5.41 Therus Corporation Company Overview
5.42 Thrombotargets Corp Company Overview
5.43 United Health Products, Inc. Company Overview
5.44 University of Grenoble Alpes Company Overview
5.45 Virginia Commonwealth University Company Overview
5.46 Xcede Technologies Inc Company Overview
5.47 Z-Medica LLC Company Overview
5.2 Acro Biomedical Co Ltd Company Overview
5.3 Advanced Biotech Products Pvt Ltd Company Overview
5.4 Angiotech Pharmaceuticals Inc Company Overview
5.5 Anika Therapeutics Inc Company Overview
5.6 APRUS Bio-Medical Innovations Pvt Ltd Company Overview
5.7 Arch Therapeutics Inc Company Overview
5.8 Baxter Healthcare Corp Company Overview
5.9 Beth Israel Deaconess Medical Center Company Overview
5.10 Biomedica Management Corp Company Overview
5.11 Biom'Up SAS Company Overview
5.12 Cellphire Inc Company Overview
5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview
5.14 Columbia University Company Overview
5.15 Covalent Medical, Inc. (Inactive) Company Overview
5.16 Covalon Technologies Ltd Company Overview
5.17 CR Bard Inc Company Overview
5.18 Cresilon Inc Company Overview
5.19 Endomedix Incorporated Company Overview
5.20 Entegrion Inc Company Overview
5.21 Ethicon US LLC Company Overview
5.22 ETX Pharma Inc Company Overview
5.23 Gamma Diagnostics Inc Company Overview
5.24 GATT Technologies BV Company Overview
5.25 Haemostatix Ltd Company Overview
5.26 Hemostasis LLC Company Overview
5.27 HLL Lifecare Ltd Company Overview
5.28 Ichor Sciences LLC Company Overview
5.29 Keratin Biosciences Inc Company Overview
5.30 Leader Biomedical Europe BV Company Overview
5.31 Medcura Inc Company Overview
5.32 Protege Biomedical LLC Company Overview
5.33 Resorba GmbH Company Overview
5.34 Rice University Company Overview
5.35 Sanofi Biosurgery Inc Company Overview
5.36 Sea Run Holdings Inc Company Overview
5.37 St Teresa Medical Inc Company Overview
5.38 STB Lifesaving Technologies Company Overview
5.39 Tectum Company Overview
5.40 The Medicines Co Company Overview
5.41 Therus Corporation Company Overview
5.42 Thrombotargets Corp Company Overview
5.43 United Health Products, Inc. Company Overview
5.44 University of Grenoble Alpes Company Overview
5.45 Virginia Commonwealth University Company Overview
5.46 Xcede Technologies Inc Company Overview
5.47 Z-Medica LLC Company Overview
6 Topical Absorbable Hemostats- Recent Developments
6.1 Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
6.2 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
6.3 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.4 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.5 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share
6.7 May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO
6.8 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
6.9 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
6.10 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
6.11 May 10, 2022: Baxter to Host 2022 Investor Conference
6.12 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
6.13 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
6.14 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022
6.15 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
6.16 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
6.17 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
6.18 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
6.19 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
6.20 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
6.21 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
6.22 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
6.23 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
6.24 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
6.25 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
6.26 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
6.27 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
6.28 Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
6.29 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
6.30 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
6.31 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
6.32 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
6.33 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
6.34 Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
6.35 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
6.36 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
6.37 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
6.38 Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board
6.39 Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors
6.40 Dec 22, 2021: United Health Products provides regulatory status update
6.41 Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors
6.42 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
6.43 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
6.44 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
6.45 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
6.46 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
6.47 Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World
6.48 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
6.49 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
6.50 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
6.51 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER
6.52 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021
6.53 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
6.54 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
6.55 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
6.56 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
6.57 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
6.58 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
6.59 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
6.60 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
6.61 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
6.62 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
6.63 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.64 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results
6.65 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
6.66 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.67 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference
6.68 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results
6.69 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021
6.70 Jul 29, 2021: Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
6.71 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
6.72 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
6.73 Jul 27, 2021: Stryker reports second quarter 2021 operating results
6.74 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
6.75 Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
6.76 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
6.77 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
6.78 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
6.79 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.2 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
6.3 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.4 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.5 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
6.6 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share
6.7 May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO
6.8 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
6.9 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
6.10 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
6.11 May 10, 2022: Baxter to Host 2022 Investor Conference
6.12 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
6.13 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
6.14 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022
6.15 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
6.16 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
6.17 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
6.18 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
6.19 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
6.20 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
6.21 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
6.22 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
6.23 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
6.24 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
6.25 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
6.26 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
6.27 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
6.28 Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
6.29 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
6.30 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
6.31 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
6.32 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
6.33 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
6.34 Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
6.35 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
6.36 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
6.37 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
6.38 Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board
6.39 Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors
6.40 Dec 22, 2021: United Health Products provides regulatory status update
6.41 Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors
6.42 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
6.43 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
6.44 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
6.45 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
6.46 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
6.47 Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World
6.48 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
6.49 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
6.50 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
6.51 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER
6.52 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021
6.53 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
6.54 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
6.55 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
6.56 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
6.57 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
6.58 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
6.59 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
6.60 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
6.61 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
6.62 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
6.63 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.64 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results
6.65 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
6.66 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.67 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference
6.68 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results
6.69 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021
6.70 Jul 29, 2021: Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
6.71 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
6.72 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
6.73 Jul 27, 2021: Stryker reports second quarter 2021 operating results
6.74 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
6.75 Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
6.76 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
6.77 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
6.78 Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
6.79 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 7.4 Disclaimer
7.2 About the Publisher
7.3 7.4 Disclaimer
List of Tables
- Topical Absorbable Hemostats - Pipeline Products by Stage of Development
- Topical Absorbable Hemostats - Pipeline Products by Segment
- Topical Absorbable Hemostats - Pipeline Products by Territory
- Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
- Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
- Topical Absorbable Hemostats - Ongoing Clinical Trials
- Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
- Topical Absorbable Hemostats - Pipeline Products by Stage of Development
- PuraStat - Product Status
- PuraStat - Product Description
- TDM-623 - Product Status
- TDM-623 - Product Description
- PuraStat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection
- PuraStat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding
- PuraStat - A Study to Evaluate the Effectiveness of Purastat in the Prevention of Delayed Bleeding after EMR of Non-ampullary Duodenal Lesions
- PuraStat - Efficacy of PuraStat for the Prevention of Delayed Bleeding after Endoscopic Resection of Colorectal Lesions
- PuraStat - Endoscopically-delivered Purastat for the Treatment of Haemorrhagic Radiation Proctopathy: A Randomised Feasibility Study
- PuraStat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
- Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- ACROHCM - Product Status
- ACROHCM - Product Description
- Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Hemocoll - Product Status
- Hemocoll - Product Description
- Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Hemaseel Thrombin Haemostatic Agent - Product Status
- Hemaseel Thrombin Haemostatic Agent - Product Description
- Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Hemostatic Patch - Product Status
- Hemostatic Patch - Product Description
- APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Deep Wound Hemostat - Product Status
- Deep Wound Hemostat - Product Description
- Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- AC5 - Burns - Product Status
- AC5 - Burns - Product Description
- AC5 - Diabetic Ulcers - Product Status
- AC5 - Diabetic Ulcers - Product Description
- AC5 - Pressure Ulcers - Product Status
- AC5 - Pressure Ulcers - Product Description
- AC5 - V - Product Status
- AC5 - V - Product Description
- AC5 Surgical Hemostatic Device - Product Status
- AC5 Surgical Hemostatic Device - Product Description
- Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
- Celstat Topical Hemostatic Dressing - Product Status
- Celstat Topical Hemostatic Dressing - Product Description
- PerClot - Product Status
- PerClot - Product Description
- Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview
- Portable Wound Hemostasis System - Product Status
- Portable Wound Hemostasis System - Product Description
- Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
- ClotFoam - Product Status
- ClotFoam - Product Description
- ClotGel - Product Status
- ClotGel - Product Description
- ClotSpray - Product Status
- ClotSpray - Product Description
- Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
- HEMOSNOW - Product Status
- HEMOSNOW - Product Description
- Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
- Thromboderm - Product Status
- Thromboderm - Product Description
- Thrombosomes - Product Status
- Thrombosomes - Product Description
- Cellphire Inc - Ongoing Clinical Trials Overview
- Thrombosomes - A Phase I, Multi-center, Open-label, Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts
- Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview
- HemoKi - Product Status
- HemoKi - Product Description
- Columbia University Pipeline Products & Ongoing Clinical Trials Overview
- Hemostatic Wound Dressing - Product Status
- Hemostatic Wound Dressing - Product Description
- Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- CovaSTAT - Product Status
- CovaSTAT - Product Description
- Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
- ColActive THP - Product Status
- ColActive THP - Product Description
- CovaStat BioActive Absorbable Hemostatic Sponge - Product Status
- CovaStat BioActive Absorbable Hemostatic Sponge - Product Description
- CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
- Absorbable Hemostat - Product Status
- Absorbable Hemostat - Product Description
- New Hemostat 1 - Product Status
- New Hemostat 1 - Product Description
- New Hemostat 2 - Product Status
- New Hemostat 2 - Product Description
- Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
- Hemostatic Gel - Product Status
- Hemostatic Gel - Product Description
- TRAUMAGEL - Product Status
- TRAUMAGEL - Product Description
- Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
- Surgical Hemostat - Intracranial Surgery - Product Status
- Surgical Hemostat - Intracranial Surgery - Product Description
- Topical Hemostat - Product Status
- Topical Hemostat - Product Description
- Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
- Stasix - Product Status
- Stasix - Product Description
- Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
- Next Gen Hemostat Kit - Product Status
- Next Gen Hemostat Kit - Product Description
- SURGIFLO - Sterile Field Preparation - Product Status
- SURGIFLO - Sterile Field Preparation - Product Description
- ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
- ETX-302 - Product Status
- ETX-302 - Product Description
- Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- GammaTF - Product Status
- GammaTF - Product Description
- GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
- GATT-Patch - Product Status
- GATT-Patch - Product Description
- GATT-Powder - Product Status
- GATT-Powder - Product Description
- Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Haemoplax - Product Status
- Haemoplax - Product Description
- PeproStat - Product Status
- PeproStat - Product Description
- Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
- ACCEL Absorbable Hemostat - Product Status
- ACCEL Absorbable Hemostat - Product Description
- ENT Hemostat - Product Status
- ENT Hemostat - Product Description
- Hemostatic Gel - Product Status
- Hemostatic Gel - Product Description
- Hemostasis LLC - Ongoing Clinical Trials Overview
- ACCEL Absorbable Hemostat - ACCEL Absorbable Hemostat Powder Clinical Trial
- HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Hinstat Ext - Product Status
- Hinstat Ext - Product Description
- Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview
- Statbond ENT - Product Status
- Statbond ENT - Product Description
- Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Keratin-Based Hemostat - Product Status
- Keratin-Based Hemostat - Product Description
- Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview
- Collagen-Based Haemostatic Device - Product Status
- Collagen-Based Haemostatic Device - Product Description
- Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview
- Hemogrip Foam - Product Status
- Hemogrip Foam - Product Description
- LifeFoam - Product Status
- LifeFoam - Product Description
- LifeGel - Product Status
- LifeGel - Product Description
- Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
- Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Status
- Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Description
- Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Antibiotic Hemostat - Product Status
- Antibiotic Hemostat - Product Description
- RESORBA - Cardiac Surgery - Product Status
- RESORBA - Cardiac Surgery - Product Description
- Rice University Pipeline Products & Ongoing Clinical Trials Overview
- KOD Hydrogel Hemostat - Product Status
- KOD Hydrogel Hemostat - Product Description
- Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
- LeSeal - Product Status
- LeSeal - Product Description
- Lumagel - Product Status
- Lumagel - Product Description
- Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
- SEA-STAT - Product Status
- SEA-STAT - Product Description
- St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Surgiclot - Product Status
- Surgiclot - Product Description
- WRAPCLOT - Product Status
- WRAPCLOT - Product Description
- STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview
- FAST Dressing - Product Status
- FAST Dressing - Product Description
- Tectum Pipeline Products & Ongoing Clinical Trials Overview
- Hemostatic Gel - Product Status
- Hemostatic Gel - Product Description
- Wound Dressing With Hemostat - Product Status
- Wound Dressing With Hemostat - Product Description
- The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview
- Fibropad Patch - Product Status
- Fibropad Patch - Product Description
- Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
- Therus Acoustic Hemostasis System - Product Status
- Therus Acoustic Hemostasis System - Product Description
- Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
- Next Generation TT-173 - Product Status
- Next Generation TT-173 - Product Description
- TT-173 - Product Status
- TT-173 - Product Description
- Thrombotargets Corp - Ongoing Clinical Trials Overview
- TT-173 - A Phase II/III, Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of Topically Applied TT-173 in Patients Undergoing Knee Arthroplasty
- United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- HemoStyp - Surgical Wounds - Product Status
- HemoStyp - Surgical Wounds - Product Description
- HemoStyp - Trauma - Product Status
- HemoStyp - Trauma - Product Description
- HemoStyp External Procedure Gauze - Product Status
- HemoStyp External Procedure Gauze - Product Description
- HemoStyp hydrocolloid - Product Status
- HemoStyp hydrocolloid - Product Description
- HemoStyp Internal Procedure Gauze - Product Status
- HemoStyp Internal Procedure Gauze - Product Description
- Hemostyp Internal Procedure Gauze - Orthopedic - Product Status
- Hemostyp Internal Procedure Gauze - Orthopedic - Product Description
- HemoStyp Trauma Gauze - Product Status
- HemoStyp Trauma Gauze - Product Description
- University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
- Bleeding Controlling Device - Product Status
- Bleeding Controlling Device - Product Description
- Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
- BioHemostat - Product Status
- BioHemostat - Product Description
- Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Xcede - Femoral Artery - Product Status
- Xcede - Femoral Artery - Product Description
- Xcede - Laparoscopic Surgery - Product Status
- Xcede - Laparoscopic Surgery - Product Description
- Xcede - Lung Sealing - Product Status
- Xcede - Lung Sealing - Product Description
- Xcede - Vascular Surgery - Product Status
- Xcede - Vascular Surgery - Product Description
- Xcede Patch - Liver Resection - Product Status
- Xcede Patch - Liver Resection - Product Description
- Z-Medica LLC Pipeline Products & Ongoing Clinical Trials Overview
- QuikClot Control+ - Class I and Class II Bleeding - Product Status
- QuikClot Control+ - Class I and Class II Bleeding - Product Description
- Z-Medica LLC - Ongoing Clinical Trials Overview
- QuikClot Control+ - Class I and Class II Bleeding - A Cardiac Investigational Device Exemption Study to Evaluate the Efficacy of QuikClot Control+ for Class I and II Bleeding in Patients Undergoing Cardiac Surgery
- Glossary
List of Figures
- Topical Absorbable Hemostats - Pipeline Products by Stage of Development
- Topical Absorbable Hemostats - Pipeline Products by Segment
- Topical Absorbable Hemostats - Pipeline Products by Territory
- Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
- Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
- Topical Absorbable Hemostats - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3-D Matrix Ltd
- Acro Biomedical Co Ltd
- Advanced Biotech Products Pvt Ltd
- Angiotech Pharmaceuticals Inc
- Anika Therapeutics Inc
- APRUS Bio-Medical Innovations Pvt Ltd
- Arch Therapeutics Inc
- Baxter Healthcare Corp
- Beth Israel Deaconess Medical Center
- Biomedica Management Corp
- Biom'Up SAS
- Cellphire Inc
- Ceramicos Para Aplicacoes Medicas SA
- Columbia University
- Covalent Medical, Inc. (Inactive)
- Covalon Technologies Ltd
- CR Bard Inc
- Cresilon Inc
- Endomedix Incorporated
- Entegrion Inc
- Ethicon US LLC
- ETX Pharma Inc
- Gamma Diagnostics Inc
- GATT Technologies BV
- Haemostatix Ltd
- Hemostasis LLC
- HLL Lifecare Ltd
- Ichor Sciences LLC
- Keratin Biosciences Inc
- Leader Biomedical Europe BV
- Medcura Inc
- Protege Biomedical LLC
- Resorba GmbH
- Rice University
- Sanofi Biosurgery Inc
- Sea Run Holdings Inc
- St Teresa Medical Inc
- STB Lifesaving Technologies
- Tectum
- The Medicines Co
- Therus Corporation
- Thrombotargets Corp
- United Health Products, Inc.
- University of Grenoble Alpes
- Virginia Commonwealth University
- Xcede Technologies Inc
- Z-Medica LLC
